• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Brett Davis named Deloitte Health Informatics general manager

Brett Davis named Deloitte Health Informatics general manager

July 3, 2013
CenterWatch Staff

Brett J. Davis has been named general manager of Deloitte Health Informatics (DHI), a newly launched business providing advanced analytics services and products to healthcare providers, researchers and medical manufacturers’ managers.

Davis, who recently joined Deloitte Consulting as a principal, will expand DHI's solutions and network of collaborators in helping health organizations reduce costs, improve outcomes and shrink time involved in developing new therapies.

Previously, Davis was senior director of business development for the health sciences global business unit of Oracle, helping launch its healthcare analytics and translational research solution areas. He has also held leadership roles at IBM's healthcare and life sciences business, most recently as a business unit executive for the public and healthcare sectors.

Davis has published white papers and has spoken at conferences and groups, and his commentary has appeared in InformationWeek, Computer World, Advanced Clinical Trials and Health Data Management.

Davis’ board affiliations include the Personalized Medicine Coalition, the Dean's Advisory Board of the Jefferson School of Population Health and the External Advisory Board of the University of Pennsylvania's Center for Bioethics.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing